Levi & Korsinsky is investigating the Board of Directors of Synovis Life Technologies, Inc. (“Synovis” or the “Company”) (NASDAQ: SYNO) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Baxter International Inc. (NYSE: BAX). Under the terms of the transaction, Synovis shareholders will receive $28 per share of Synovis stock they own. The transaction has a total approximate value of $325 million.
Click here to learn how to join the action:
, or call: 877-363-5972.
The investigation concerns whether the Synovis Board of Directors breached their fiduciary duties to Synovis stockholders by failing to adequately shop the Company before entering into this transaction and whether Baxter International Inc. is underpaying for Synovis shares, thus unlawfully harming Synovis stockholders.
If you own common stock in Synovis and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at
or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or
Levi & Korsinsky has extensive expertise in prosecuting investor securities litigation involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.